0% found this document useful (0 votes)
5 views41 pages

Geriatric Pharmacology DO 22

Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1/ 41

Geriatric Pharmacology

Physiology, Pharmacology, and Prescribing

Roy Krishna, Ph.D. FCP.


Touro University, Nevada.
Challenges of Prescribing
for Older Adults
• Multiple chronic medical problems
• Multiple medications and prescribers
• Different metabolism and responses
• Adherence and cost
• Supplements, herbals, and OTC drugs
• POLYPHARMACY!!!!!!!!!
Lancet. 1995;346(8966):32–36. 2
Physiologic Changes Associated
with Normal Aging
• Less Water
• More Fat
• Less muscle mass
• Slowed hepatic metabolism
• Decreased renal excretion
• Decreased responsiveness and sensitivity of the
baroreceptor reflex

3
Absorption
 Not affected by the normal aging process
 Can be altered by drug interactions
 Antacids
 Iron
 Can be affected by pathophysiology
 Lack of intrinsic factor (B12 absorption)
 Delayed gastric emptying
 GERD, Crohns, Ulcerative Colitis.

4
Distribution
 Less water = ↓ volume of distribution = higher
concentration of water soluble drugs
(aminoglycosides?)

 More fat = ↑ volume of distribution = prolonged action


of fat soluble drugs (increased half-life, redistribution-
barbiturates, benzodiazepines))

 Lower serum proteins (like albumin) increases the


concentration of unbound (free or active) form of
drugs-Digoxin, Theophylline, NSAID,s.
5
Metabolism
 Slowed Phase I, cytochrome P450, reactions
 Oxidation, reduction, dealkylation
 Warfarin and phenytoin levels may be higher because of
altered metabolism

 Phase II reactions are essentially unchanged


 Conjugation, acetylation, methylation

 Drug-drug interactions
 Increased risk with increased number of drugs-
polypharmacy-Warfarin, Digoxin, Theophyline, Macrolides.
6
CYTOCHROME P-450 CYP3A
Metabolizes: Induced by:
 Fentanyl, methadone,  Barbiturates
 Acetaminophen  Carbamazepine
 Erythro, Clarithromycin  Glucocorticoids
 Itra- and ketoconazole,  Phenytoin
 Amiodarone, lidocaine,
quinidine, Inhibited by:
 Calcium channel blockers \ Cimetidine
 Cisapride \ Erythro, clarithromycin
 Sertraline, nefazadone \ Diltiazem, nicardipine,
 Alprazolam, zolpidem, triazolam verapamil
 Astemizole, loratadine, \ Itra-, ketoconozole
terfenadine \ Fluoxetine, methylphenidate
 Cyclosporine
 Sex hormones, cortisol
 Carbamazepine
Grapefruit Juice Interaction With
Felodipine________________________________
_________________
Excretion
 Hepatic

 Renal
 Renal clearance may be reduced
 Serum creatinine may not be an accurate reflection of
renal clearance in elderly patients (decreased lean
body mass).

 Active drug metabolites may accumulate


 Prolonged therapeutic action
 Adverse effects

9
STAGES OF CHRONIC KIDNEY DISEASE.
NKF K/DOQ GUIDELINES, 2000
_________________________________
____
STAGE DESCRIPTION GFR(mL/min/1.74 m2)

1 Kidney damage with > 90


normal or increased
GFR
2 Kidney damage with 60-90
mild decreased GFR
3 Moderate decreased 30-59
GFR
4 Severe decreased GFR 15-29
5 Kidney failure < 15
11
Physiologic Changes Associated
with Disease States
 Cardiac Disease
 Impaired cardiac output (decreased absorption,
metabolism, clearance)
 Greater susceptibility to cardiac adverse effects

 Kidney and Liver Disease


 Decreased drug clearance

 Neurological Diseases
 Diminished neurotransmitter levels
 Impaired cerebral bloodflow
 Greater sensitivity to neurological effects

12
Dangers of Multiple Medications:
“Polypharmacy”
• Adverse effects (side effects)

• Drug-drug interactions

• Duplication of drug therapy

• Poor adherence
• Cost
• Decreased quality of life
13
ADVERSE DRUG REACTIONS

_________________________________
___
Side Effects

Amplified Drug-Drug
Drug Effects Interaction

ADRs

Drug-Nutrient Drug-disease
Interaction Interaction
ADRs: RISK FACTORS

___________________________________
_

# of Drugs

# of Medical
Prior ADRs
Problems

ADRs

High Risk Fragmented


Drugs Care
Adverse Drug Events (ADEs)
 Adverse symptoms

 Adverse patient outcomes


 Doctor visits or hospitalizations
 Falls
 Functional decline
 Changes in cognition (delirium)
 Death

 ↑ number of medications = ↑ risk of ADEs


(even if all the meds are “clinically indicated”)

16
Medications Which Account for
Most ADEs in Older Adults
 Cardiovascular medications

 Psychotropic medications

 Antibiotics

 Anticoagulants

 Non-opioid analgesics (NSAIDS)

 Anti-seizure medications

(JAGS 2004;52:1349-1354 and NEJM 2003;348:1556-64)


17
Risk Factors for
Adverse Drug Events (ADE)
 >6 chronic disease
 >12 doses/day
 ≥ 9 medications
 Low BMI (<22kg/m2)
 Age >85 years
 Creatinine clearance < 50 mL/min
 History of prior ADE

Consult Pharm 1997;12:1103-11.


18
Do You Need to prescribe?
• Does every condition need a drug?
• Is it a benign or self limited condition?
• How does this condition bother the patient?

• Consider non-drug alternatives


• Diet
• Exercise
• Lifestyle modification

• Consider “Over The Counter” (OTC) medications


• Not necessarily safer than prescription drugs
• Be very careful with herbals and supplements
19
Clinical Case: Mr. Johnson
Mr. Johnson is 83 years old. He has a history of benign
prostatic hypertrophy (BPH) and hypertension. After
visiting his grandchildren, he developed a viral upper
respiratory infection. He took an over-the-counter cold
remedy containing a decongestant and
diphenhydramine. He now comes to the office because
he is unable to urinate. His blood pressure is 190/80.

What happened?

20
Urinary Retention and Hypertension
 Parasympathetic Nervous System
 Mediates detrusor muscle contraction
 Blocked by anticholinergic medications like
diphenhydramine

 Sympathetic Nervous System


 α-adrenergic activity causes the urethral sphincter to
contract (retaining urine)
 α-adrenergic activity increases systemic vascular
resistance (raises blood pressure)
 Decongestants are alpha-adrenergic agonists (ex.
pseudoephedrine and phenylephrine)
21
Clinical Case: Mr. Johnson
Since Mr. Johnson has a history of benign
prostatic hypertrophy, his physician prescribes
terazosin, a peripherally-acting α1-adrenergic
antagonist, to help with his urinary retention and
to help reduce his blood pressure.

Two days later, Mr. Johnson falls in the middle of


the night, on the way to the bathroom. He
fractures his hip.

What happened?

22
Orthostatic Hypotension
and Hip Fracture
 Barorecptor sensitivity decreases with age

 α-adrenergic blockade can worsen


postural hypotension and increase the risk
of falls

 Falls and Hip fractures are associated with


significant morbidity and mortality in older
adults
23
Prescribing Cascade:
Prescribing a new drug to treat an ADE

• Establish the diagnosis


• Diphenhydramine and the decongestant precipitated urinary
retention in a older male with prostatic enlargement
• Urinary retention is an ADE

• Stop (or reduce) the offending medications


• OTC cold medicine
• Need to ask about ALL medications

• Avoid prescribing new medications (terazosin)


24
Before making a new diagnosis:
“Think Drugs”
• Consider ADE as etiology of new signs/symptoms

• Remember that OTC drugs, supplements, and herbals


can cause ADEs

• Consider discontinuing or dose-reducing medications


rather than treating an ADE with another medication

25
Clinical Case: Mr. Johnson
Mr. Johnson arrives in the emergency department
and is given meperidine (Demerol) for his pain.

He is also very anxious, so he receives diazepam


(Valium).

A few hours later, Mr. Johnson becomes very


confused and somnolent.

What happened?
26
Drug-Induced Delirium
 Meperidine
 Can cause confusion
 Active metabolites
 Slow renal clearance in older adults

 Diazepam
 Long-acting benzodiazepine
 Lipophilic
 Extended half-life in elderly
 Increased sensitivity in the elderly
 Increased risk of falls and fractures

27
Anticholinergic Medications
• Drug classes
• Antihistamines
• Tricyclic antidepressants
• Antispasmodics and muscle
relaxants

• Adverse Effects
• Dry Mouth
• Urinary retention
• Constipation
• Confusion, delirium

28
Cardiovascular Drugs
 Dihydropyridines-greater response in
treatment-naïve elderly.
 Non-dihydropyridines: Enhanced HR and
BP responses

29
Autonomic Agents
β-sensitivity decreases with age
- prevalence of high-affinity receptors ↓ with
age; does not explain diminished response to
β antagonists
- may be related to G proteins
-adrenoceptors couple with G proteins
(G proteins ↓ with age)
exception: activity of β-blockers in elderly with very
high blood pressure
α-sensitivity has shown varied responses
Interacting Drugs Impact Mechanism Prevention
Warfarin, NSAIDs Increased risk of NSAIDs irritate gastric lining & Monitor weekly INR and for
bleeding impair platelet function s/s of bleeding
Warfarin, sulfa Increased warfarin Change in gut flora responsible Dec. warfarin dose by 50%
activity for K production during and 1 wk after abx
Warfarin, macrolide Increased effect of E-mycin inhibits warfarin metab. If macrolide necessary,
(highly probably, often delayed) warfarin and clearance; change in gut monitor INR qod. ID
flora pathogen to confirm need.
Warfarin, quinolones Increased effect of Change in gut flora; decrease in Monitor INR qod if
warfarin hepatic warfarin metabolism quinolone is necessary
Warfarin, phenytoin Increased effects of Keep INR at lower end of
both drugs thx range. Monitor INR and
PTN lvl.
ACE-inhibitors, K+ supplements Elevated serum K+ Decreased aldosterone/K+ Monitor K+; are both drugs
secretion necessary?
ACE-inhibitors, aldactone/ Elevated serum K+ Probably additive effect Monitor K+; are both drugs
spironolactone necessary?
Digoxin, amiodarone Digoxin toxicity ? amio ↓ clearance of digoxin; ? Dig lvl prior to amiodarone;
additive effect at sinus note decrease dig dose and
monitor weekly
Digoxin, verapamil Digoxin toxicity, Synergistic effect of slowed Monitor HR and EKG (PR
bradycardia, heart impulse conduction and interval)
block reduced contractility
Theophylline, quinolones Theophylline toxicity Quinolones inhibit hepatic Monitor theophylline lvl
metabolism of theophylline AND watch for s/s
Serotonin Syndrome
Caused by
elevated levels of
serotonin
-too high a dose of
some medications
-medication
combinations
-some illicit drugs and
herbal supplements
Signs/Symptoms:
agitation, confusion,
tachycardia,
headache,
diaphoresis, diarrhea
POTENTIAL INTERACTIONS BETWEEN
HERBAL MEDICINES AND CONVENTIONAL
MEDICINES
St. John’s wort is a potent inducer of the CYP3A4
and the P-glycoprotein drug transporter.

 Inhibit HIV protease inhibitors


 Inhibit some immunosuppressants
 Inhibit antineoplastic agents
 Interact with antidepressants
 Interact with warfarin
POTENTIAL INTERACTIONS BETWEEN
HERBAL MEDICINES AND CONVENTIONAL
MEDICINES

Other potential (frequently used) herb-drug


interactions

 Ginkgo and Aspirin


 Ginkgo and Trazodone
 Ginseng and Amlodipine
 Valerian and Lorazepam
 Antiepileptics and herbals!
Suggested Maximum Daily Dosages for
Older Adults
 Benzodiazepines/ Hypnotics
• Lorazepam, 3 mg --Temazepam, 15 mg
• Oxazepam, 60 mg -- Zolpidem, 5 mg
• Alprazolam, 2 mg -- Triazolam, 0.25 mg
 Iron Supplements, 325 mg
 Digoxin, 0.125 mg
Avoiding Potentially Dangerous Drugs:

• Anticholinergic medications
• Decongestants
• Hypertension
• Bladder outflow obstruction
• Meperidine
• Benzodiazepines

Beers Criteria: Arch Intern Med 2003;163:2721.


37
“If You Decide to Prescribe,
Start Low and Go Slow…”
• Start one medication at a time

• Start with a low dose and increase gradually

• Monitor for response

• Monitor and anticipate adverse effects

• Assess adherence with regimen


38
Adherence

 Multiple medications  Language and literacy

 Multiple doses  Cost

 Sensory impairments  Quality of Life


 Adverse Effects
 Physical impairments
 “Medicalization”
 Memory impairment

39
Increasing Adherence

 Keep the medication list short

 Try to use once daily medications

 Encourage use of a pillbox

 Review bottles of medications

 Write indications for medications on prescriptions

 Medication Management programs

40
Things to Remember:
Changes with Aging
 Absorption usually does not change

 Higher concentrations of water soluble and free


(unbound) drugs

 Longer half-life for lipophilic drugs

 Slower phase I metabolism

 Impaired excretion

 Increased susceptibility to adverse effects


41

You might also like